1 completed. 1 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Completed 1 |
| Phase 3 | 1 | Completed 1 |
Follow leniolisib: new trials by email Literature Review of leniolisib trials Research Report on leniolisib
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study of Efficacy of CDZ173 in Patients With APDS/PASLI CDZ173, Placebo - Common Variable Immunodeficiency (CVID), APDS / PASLI | Phase 2 / Phase 3 | Completed | Novartis Pharmaceuticals | 37 | 2015-08-24 | 2022-08-10 |
Activated PI3K-delta Syndrome (1) · Common Variable Immunodeficiency (1)
Belarus (1) · Czechia (1) · Germany (1) · Ireland (1) · Italy (1) · Netherlands (1) · Russia (1) · United Kingdom (1) · United States (1)
Koneti V Rao, MD (1) · Virgil Dalm, MD (1)
PMID 28972011, PMID 36399712, PMID 41091701
2014 (1)